These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 18177322)
1. Pharmacokinetics of ivermectin in pregnant and nonpregnant sheep. Pérez R; Palma C; Núñez MJ; Cox J; Arboix M J Vet Pharmacol Ther; 2008 Feb; 31(1):71-6. PubMed ID: 18177322 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of ivermectin after maternal or fetal intravenous administration in sheep. Pérez R; Palma C; Núñez MJ; Cox J J Vet Pharmacol Ther; 2008 Oct; 31(5):406-14. PubMed ID: 19000259 [TBL] [Abstract][Full Text] [Related]
3. Combined subcutaneous administration of ivermectin and nitroxynil in sheep: age/body weight related changes to the kinetic disposition of both compounds. Moreno L; Ceballos L; Lifschitz A; Bistoletti M; Alvarez L; Lanusse C Res Vet Sci; 2010 Apr; 88(2):315-20. PubMed ID: 19892381 [TBL] [Abstract][Full Text] [Related]
4. Effect of parasitism on the pharmacokinetic disposition of ivermectin in lambs. Pérez R; Palma C; Cabezas I; Araneda M; Rubilar L; Alvinerie M J Vet Med A Physiol Pathol Clin Med; 2006 Feb; 53(1):43-8. PubMed ID: 16411909 [TBL] [Abstract][Full Text] [Related]
5. Bioavailability of a commercial formulation of ivermectin after subcutaneous administration to sheep. Canga AG; Sahagun A; Diez MJ; Fernandez N; Sierra M; Garcia JJ Am J Vet Res; 2007 Jan; 68(1):101-6. PubMed ID: 17199426 [TBL] [Abstract][Full Text] [Related]
6. Plasma disposition kinetics of moxidectin after subcutaneous administration to pregnant sheep. Pérez R; Núñez MJ; Palma C; Riquelme J; Arboix M J Vet Pharmacol Ther; 2014 Dec; 37(6):550-5. PubMed ID: 24731163 [TBL] [Abstract][Full Text] [Related]
7. Involvement of P-glycoprotein on ivermectin kinetic behaviour in sheep: itraconazole-mediated changes on gastrointestinal disposition. Ballent M; Lifschitz A; Virkel G; Sallovitz J; Lanusse C J Vet Pharmacol Ther; 2007 Jun; 30(3):242-8. PubMed ID: 17472656 [TBL] [Abstract][Full Text] [Related]
8. Comparative pharmacokinetics of some injectable preparations containing ivermectin in dogs. Eraslan G; Kanbur M; Liman BC; Cam Y; Karabacak M; Altinordulu S Food Chem Toxicol; 2010; 48(8-9):2181-5. PubMed ID: 20488222 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of ivermectin in zebu Gobra (Bos indicus). Ndong TB; Kane Y; Ba MA; Sane I; Sutra JF; Alvinerie M Vet Parasitol; 2005 Mar; 128(1-2):169-73. PubMed ID: 15725548 [TBL] [Abstract][Full Text] [Related]
10. Breed differences in the pharmacokinetics of ivermectin administered subcutaneously to Holstein and Belgian Blue calves. Vercruysse J; Deprez P; Everaert D; Bassissi F; Alvinerie M Vet Parasitol; 2008 Mar; 152(1-2):136-40. PubMed ID: 18207642 [TBL] [Abstract][Full Text] [Related]
11. Faecal excretion profile of moxidectin and ivermectin after oral administration in horses. Pérez R; Cabezas I; Sutra JF; Galtier P; Alvinerie M Vet J; 2001 Jan; 161(1):85-92. PubMed ID: 11145833 [TBL] [Abstract][Full Text] [Related]
12. Ivermectin (3.15%) long-acting formulations in cattle: absorption pattern and pharmacokinetic considerations. Lifschitz A; Virkel G; Ballent M; Sallovitz J; Imperiale F; Pis A; Lanusse C Vet Parasitol; 2007 Jul; 147(3-4):303-10. PubMed ID: 17524559 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of ivermectin in sheep following pretreatment with Escherichia coli endotoxin. Riquelme J; Cazanga V; Jeldres J; Pérez R J Vet Pharmacol Ther; 2018 Oct; 41(5):755-759. PubMed ID: 29889311 [TBL] [Abstract][Full Text] [Related]
14. Breed-related plasma disposition of ivermectin following subcutaneous administration in Kilis and Damascus goats. Gokbulut C; Bilgili A; Hanedan B; Aksit D; Aksoy AM; Turgut C Res Vet Sci; 2009 Dec; 87(3):445-8. PubMed ID: 19410269 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of a novel formulation of ivermectin after administration to goats. González A; Sahagun AM; Diez MJ; Fernandez N; Sierra M; Garcia JJ Am J Vet Res; 2006 Feb; 67(2):323-8. PubMed ID: 16454640 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of azithromycin and the combination of ivermectin and albendazole when administered alone and concurrently in healthy volunteers. Amsden GW; Gregory TB; Michalak CA; Glue P; Knirsch CA Am J Trop Med Hyg; 2007 Jun; 76(6):1153-7. PubMed ID: 17556628 [TBL] [Abstract][Full Text] [Related]
17. Sex-related plasma disposition of ivermectin following pour-on administration in goats. Gokbulut C; Bilgili A; Hanedan B; Aksit D; Aksoy AM; Turgut C Vet Parasitol; 2009 Jun; 162(3-4):342-5. PubMed ID: 19342177 [TBL] [Abstract][Full Text] [Related]
18. Comparative plasma disposition, bioavailability and efficacy of ivermectin following oral and pour-on administrations in horses. Gokbulut C; Cirak VY; Senlik B; Aksit D; Durmaz M; McKellar QA Vet Parasitol; 2010 May; 170(1-2):120-6. PubMed ID: 20181429 [TBL] [Abstract][Full Text] [Related]
19. Multiple oral dosing of ketoconazole increases dog exposure to ivermectin. Hugnet C; Lespine A; Alvinerie M J Pharm Pharm Sci; 2007; 10(3):311-8. PubMed ID: 17727794 [TBL] [Abstract][Full Text] [Related]
20. Transplacental exchange of moxidectin after maternal or fetal intravenous administration in sheep. Pérez R; Palma C; Núñez MJ; Navas M; Olmos G; Cox J J Vet Pharmacol Ther; 2009 Dec; 32(6):596-605. PubMed ID: 20444015 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]